Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 212 entries
View as:

Vebreltinib Combined With Temozolomide for Glioblastoma (GBM) After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06780592 Org: User:
Start: 01/13/25 End: 12/31/27 Due: 12/31/28

Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01758536 Org: User:
Start: 12/31/12 End: 12/31/14 Due: 12/31/15

Identification of Interscalene Brachial Plexus on Ultrasonography Using a Deep Neural Network

Phase: N/A Priority: Normal
NCT ID: NCT04183972 Org: User:
Start: 12/01/19 End: 10/31/20 Due: 10/31/21

Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion

Phase: N/A Priority: Normal
NCT ID: NCT06550622 Org: User:
Start: 08/10/24 End: 08/10/27 Due: 08/10/28

The Adult Hemorrhagic Moyamoya Surgery Study

Phase: N/A Priority: Normal
NCT ID: NCT02319980 Org: User:
Start: 05/31/15 End: 05/31/23 Due: 05/31/24

The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT03058198 Org: User:
Start: 01/31/17 End: 12/31/20 Due: 12/31/21

Reactogenicity and Immunogenicity of Third Dose Vaccine Booster Following Two Doses of Inactivated Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT05095298 Org: User:
Start: 08/01/21 End: 08/01/22 Due: 08/01/23

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

Phase: N/A Priority: Normal
NCT ID: NCT06324058 Org: User:
Start: 03/18/24 End: 03/18/26 Due: 03/18/27

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets

Phase: N/A Priority: Normal
NCT ID: NCT06966635 Org: User:
Start: 04/10/24 End: 04/30/26 Due: 04/30/27

Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD

Phase: N/A Priority: Normal
NCT ID: NCT01820832 Org: User:
Start: 03/31/13 End: 06/30/15 Due: 06/30/16

Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND)

Phase: N/A Priority: Normal
NCT ID: NCT01872858 Org: User:
Start: 11/30/10 End: 11/30/15 Due: 11/30/16

The Effects of Multidomain Non-pharmacological Interventions on the Elderly With or Without Mild Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05483790 Org: User:
Start: 06/01/20 End: 12/31/24 Due: 12/31/25

Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD

Phase: N/A Priority: Normal
NCT ID: NCT03277001 Org: User:
Start: 10/01/17 End: 12/31/19 Due: 12/31/20

A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL

Phase: N/A Priority: Normal
NCT ID: NCT05036577 Org: User:
Start: 10/10/21 End: 09/30/25 Due: 09/30/26

Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01258322 Org: User:
Start: 01/31/08 End: 09/30/08 Due: 09/30/09

Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT04197492 Org: User:
Start: 12/16/19 End: 12/31/24 Due: 12/31/25

Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04201730 Org: User:
Start: 12/25/19 End: 06/01/21 Due: 06/01/22

PDO Based Drug Sensitive Test in R/M HNSCC

Phase: N/A Priority: Normal
NCT ID: NCT06686342 Org: User:
Start: 11/11/24 End: 11/11/28 Due: 11/11/29

Real World Study of Classic Infectious Disease

Phase: N/A Priority: Normal
NCT ID: NCT04020536 Org: User:
Start: 05/13/20 End: 06/01/29 Due: 06/01/30

[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06165874 Org: User:
Start: 03/12/23 End: 01/14/24 Due: 01/14/25

Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT06515132 Org: User:
Start: 01/10/25 End: 05/30/26 Due: 05/30/27

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05204602 Org: User:
Start: 02/10/22 End: 12/20/22 Due: 12/20/23

Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction

Phase: N/A Priority: Normal
NCT ID: NCT03641391 Org: User:
Start: 09/01/18 End: 12/01/23 Due: 12/01/24

Spinal Cord Stimulation in Patients With Disorders of Consciousness

Phase: N/A Priority: Normal
NCT ID: NCT04010838 Org: User:
Start: 07/01/19 End: 06/30/23 Due: 06/30/24

Tumor Vaccines for Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06102837 Org: User:
Start: 10/31/23 End: 10/31/27 Due: 10/31/28